Svetlana Vasilieva

Dr. Svetlana Vasilieva

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DKDaria A. Kamaeva
Daria A. Kamaeva
LSLiudmila Smirnova
Liudmila Smirnova
SVSvetlana Vasilieva
Svetlana Vasilieva
DKDaria V. Kazantseva
Daria V. Kazantseva
AVAlisa R. Vasilieva
Alisa R. Vasilieva
SISvetlana Ivanova
Svetlana Ivanova
The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first time, we have shown that IgGs isolated from sera of bipolar patients can effectively hydrolyze human myelin basic protein (MBP), unlike other test proteins. Several stringent criteria were applied to assign the studied activity to serum IgG. The level of MBP-hydrolyzing activity of IgG from patients with bipolar disorder was statistically significantly 1.6-folds higher than that of healthy individuals. This article presents a detailed characterization of the catalytic properties of MBP-hydrolyzing antibodies in bipolar disorder, including the substrate specificity, inhibitory analysis, pH dependence of hydrolysis, and kinetic parameters of IgG-dependent MBP hydrolysis, providing the heterogeneity of polyclonal MBP-hydrolyzing IgGs and their difference from canonical proteases. The ability of serum IgG to hydrolyze MBP in bipolar disorder may become an additional link between the processes of myelin damage and inflammation.

9 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMarina Khodanovich
Marina Khodanovich
MSMikhail Svetlik
Mikhail Svetlik
DKDaria A. Kamaeva
Daria A. Kamaeva
AUAnna Usova
Anna Usova
MKMarina Kudabaeva
Marina Kudabaeva
Anna V. NaumovaAnna V. Naumova
Anna V. Naumova
Background: Depression is one of the most severe sequelae of COVID-19, with major depressive disorder often characterized by disruption in white matter (WM) connectivity stemming from changes in brain myelination. This study aimed to quantitatively assess brain myelination in clinically diagnosed post-COVID depression (PCD) using the recently proposed MRI method, macromolecular proton fraction (MPF) mapping. Methods: The study involved 63 recovered COVID-19 patients (52 mild, 11 moderate, and 2 severe) at 13.5 ± 10.0 months post-recovery, with matched controls without prior COVID-19 history (n = 19). A post-COVID depression group (PCD, n = 25) was identified based on psychiatric diagnosis, while a comparison group (noPCD, n = 38) included participants with neurological COVID-19 complications, excluding clinical depression. Results: Fast MPF mapping revealed extensive demyelination in PCD patients, particularly in juxtacortical WM (predominantly occipital lobe and medial surface), WM tracts (inferior fronto-occipital fasciculus (IFOF), posterior thalamic radiation, external capsule, sagittal stratum, tapetum), and grey matter (GM) structures (hippocampus, putamen, globus pallidus, and amygdala). The noPCD group also displayed notable demyelination, but with less magnitude and propagation. Multiple regression analysis highlighted IFOF demyelination as the primary predictor of Hamilton scores, PCD presence, and severity. The number of post-COVID symptoms was a significant predictor of PCD presence, while the number of acute symptoms was a significant predictor of PCD severity. Conclusions: This study, for the first time, reveals extensive demyelination in numerous WM and GM structures in PCD, outlining IFOF demyelination as a key biomarker.

Verified
Journal Article
Open access
PDF file
MKMarina Khodanovich
Marina Khodanovich
Anna V. NaumovaAnna V. Naumova
Anna V. Naumova
DKDaria A. Kamaeva
Daria A. Kamaeva
VOVictoria Obukhovskaya
Victoria Obukhovskaya
SVSvetlana Vasilieva
Svetlana Vasilieva
MSMikhail Svetlik
Mikhail Svetlik
Background: Depression and cognitive impairment are recognized complications of COVID-19. This study aimed to assess cognitive performance in clinically diagnosed post-COVID depression (PCD, n = 25) patients using neuropsychological testing. Methods: The study involved 71 post-COVID patients with matched control groups: recovered COVID-19 individuals without complications (n = 18) and individuals without prior COVID-19 history (n = 19). A post-COVID depression group (PCD, n = 25) was identified based on psychiatric diagnosis, and a comparison group (noPCD, n = 46) included participants with neurological COVID-19 complications, excluding clinical depression. Results: The PCD patients showed gender-dependent significant cognitive impairment in the MoCA, Word Memory Test (WMT), Stroop task (SCWT), and Trail Making Test (TMT) compared to the controls and noPCD patients. Men with PCD showed worse performances on the SCWT, in MoCA attention score, and on the WMT (immediate and delayed word recall), while women with PCD showed a decline in MoCA total score, an increased processing time with less errors on the TMT, and worse immediate recall. No differences between groups in Sniffin’s stick test were found. Conclusions: COVID-related direct (post-COVID symptoms) and depression-mediated (depression itself, male sex, and severity of COVID-19) predictors of decline in memory and information processing speed were identified. Our findings may help to personalize the treatment of depression, taking a patient’s gender and severity of previous COVID-19 disease into account.

16 April 2020 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
SVSvetlana Vasilieva
Svetlana Vasilieva
GSGerman Simutkin
German Simutkin
ESEvgeny Schastnyy
Evgeny Schastnyy
ELE. V. Lebedeva
E. V. Lebedeva
NBNikolay A. Bokhan
Nikolay A. Bokhan
Аффективные расстройства при коморбидности с алкогольной зависимостью: клинико-динамические особенности, уровень социальной адаптации больных

25 June 2021 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
SGStanislav Galkin
Stanislav Galkin
SVSvetlana Vasilieva
Svetlana Vasilieva
SISvetlana Ivanova
Svetlana Ivanova
NBNikolay A. Bokhan
Nikolay A. Bokhan
Электроэнцефалографические маркеры устойчивости депрессивных расстройств к фармакотерапии и определение возможного подхода к индивидуальному прогнозу эффективности терапии

4 July 2022 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
SVSvetlana Vasilieva
Svetlana Vasilieva
GSG. G. Simutkin
G. G. Simutkin
ESE. D. Schastnyy
E. D. Schastnyy
ELE. V. Lebedeva
E. V. Lebedeva
NBNikolay A. Bokhan
Nikolay A. Bokhan
Влияние несвоевременной диагностики биполярного аффективного расстройства на основные клинико- динамические характеристики заболевания, суицидальное поведение и уровень социальной адаптации пациентов